Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: The PANAMA study

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 5, 2011, Pages 579-585

  Barrios, Vivencio ^a   Llisterri, José Luis ^b   Escobar, Carlos ^c   Alfaro, Pilar ^b   Colado, Francisco ^b   Ridocci, Francisco ^d   Matali, Arantxa ^e  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Primary Care Center Ingeniero Joaquin Benlloch   (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e Medical Department Almirall ^*  (Spain)

Author keywords

BNP; echocardiogram; heart failure; primary care

Indexed keywords

NATRIURETIC PEPTIDE TYPE B; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARDIOMEGALY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC DYSFUNCTION; DYSLIPIDEMIA; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; RADIOGRAPHY; RISK FACTOR; SEDENTARY LIFESTYLE; SENSITIVITY AND SPECIFICITY; SMOKING; SPAIN;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 79959271819     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.28     Document Type: Article

References (23)

1. Senni M, Tribouilloy CM, Rodeheffer RJ et al.Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch. Intern. Med. 159, 29-34 (1999). (Pubitemid 29044116)
2. Dickstein K, Cohen-Solal A, Filippatos G et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Eur. Heart J. 29, 2388-2442 (2008)
3. McMurray JJ, Stewart S. Heart failure. Epidemiology, aetiology, and prognosis of heart failure. Heart 83, 596-602 (2000) (Pubitemid 30316742)
4. Mant J, Doust J, Roalfe A et al.Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health. Technol. Assess. 13, 1-207 (2009)
5. Barrios V, Escobar C, De La Sierra A, Llisterri JL, González- Segura D. Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting. Blood Press. 19, 301-307 (2010)
6. Kelder JC, Rutten FH, Hoes AW. Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure. Fam. Pract. 26, 69-74 (2009)
7. Barrios V, Calderón A, Escobar C et al.Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study. J. Hypertens. 25, 1967-1973 (2007) (Pubitemid 47356639)
8. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N. Engl. J. Med. 339, 321-328 (1998) (Pubitemid 28366422)
9. Rutten FH, Cramer MJ, Zuithoff NP et al.Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur. J. Heart. Fail. 9, 651-659 (2007) (Pubitemid 46711268)
10. Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, Bachmann LM. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch. Intern. Med. 166, 1073-1080 (2006) (Pubitemid 43765178)
11. Maisel A, Mueller C, Adams K Jr et al.State of the art: using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 10, 824-839 (2008)
12. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 285, 1441-1446 (1971)
13. Mancia G, De Backer G, Dominiczak A et al.2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J. Hypertens. 25, 1105-1187 (2007) (Pubitemid 46924065)
14. van Heur LM, Baur LH, Tent M et al.Evaluation of an open-access echocardiography service in the Netherlands: a mixed methods study of indications, outcomes, patient management and trends. BMC. Health. Serv. Res. 10, 37 (2010)
15. Di Angelantonio E, Chowdhury R, Sarwar N et al.B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120, 2177-2187 (2009)
16. Barrios V, Escobar C, Calderón A, Echarri R, González-Pedel V, Ruilope LM; CONTROLRISK Investigators. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J. Hum. Hypertens. 21, 479-485 (2007) (Pubitemid 46813599)
17. Betti I, Castelli G, Barchielli A et al.The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J. Card. Fail. 15, 377-384 (2009)
18. Zuber M, Cuculi F, Attenhofer Jost CH et al.Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure. Scand. Cardiovasc. J. 43, 324-329 (2009)
19. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J. Card. Fail. 11(Suppl. 5), S15-S20 (2005)
20. Olofsson M, Boman K. Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients. Scand. J. Prim. Health Care 28, 29-35 (2010).
21. Fuat A, Murphy JJ, Hungin AP et al.The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br. J. Gen. Pract. 56, 327-333 (2006)
22. Reinhold T, Berghöfer A, Willich SN. Is the determination of biomarkers worth its price? Review of the literature taking brain natriuretic peptides (BNP) as an example. Herz 35, 1-10 (2010)
23. Bolt CL, Baur L, Stoffers J, Lenderink T, Winkens R. Novel strategies for the detection of systolic and diastolic heart failure. Curr. Cardiol. Rev. 5, 112-118 (2009).